With the analysis among 2,313 patents, we discovered top 307 key players by total patent application. Novartis AG, Gilead Sciences, Inc., Purdue Pharma LP are dominant in this area. They take 22.78% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 347
California, United States
Patent: 93
Connecticut, United States
Patent: 87
Janssen Sciences Ireland Unlimited Co.
Elan Pharma International Ltd.
California, United States
Patent: 40
Pennsylvania, United States
Patent: 36
Rhodes Pharmaceuticals LP
North Carolina, United States
Patent: 25
With the analysis among 40 patents, we discovered top 6 start-ups by total patent application. Prilenia Therapeutics Development Ltd., Noden Pharma DAC, Small Pharma Ltd. are active in this area.
Prilenia Therapeutics Development Ltd.
DUBLIN, Ireland
Patent: 11
New York, United States
Patent: 2
With the analysis among related 422 patents applied in the last 5 years. We discover 89 most active companies in this area. The fast-growing DSM IP Assets BV, Sunovion Pharmaceuticals, Inc., Gilead Sciences, Inc. take 16.35% of patent filing during this period.
Sunovion Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 19
California, United States
Patent: 19
Auckland, New Zealand
Patent: 16
Janssen Sciences Ireland Unlimited Co.
KalVista Pharmaceuticals Ltd.
Otsuka Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 13
British Columbia, Canada
Patent: 10
With the analysis among related 422 patents in last 5 years, we discover 60 new entrants. DSM IP Assets BV, AFT Pharmaceuticals Ltd., KalVista Pharmaceuticals Ltd. are the most active new entrants in this area.
Auckland, New Zealand
Patent: 16
KalVista Pharmaceuticals Ltd.
Otsuka Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 13
British Columbia, Canada
Patent: 10
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 10
AusCann Group Holdings Ltd.
Massachusetts, United States
Patent: 8
With the analysis among 59 patents, we discovered top 8 universities and scientific research institutions by total patent application. Ruprecht-Karls-Universität Heidelberg, China Pharmaceutical University, Albert Einstein College of Medicine, Inc. are dominant in this area. They take 42.37% of the total patent filing.
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 6
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 5
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 5
Beijing Shi, China
Patent: 1
Xizang Zizhiqu, China
Patent: 1
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 1